default author photo

Paul Henri Cottu

École Normale Supérieure - PSL Research University - Institut Curie

26 rue d'Ulm

Paris cedex 05

Paris, 75248

France

  • École Normale Supérieure - PSL Research University - Institut Curie

SCHOLARLY PAPERS

3

DOWNLOADS

226

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Association between Daily Timing of Everolimus Combined with Adjuvant Endocrine Therapy with Survival Outcomes in Patients with High-Risk Hormone Positive and Her2 Negative Early Breast Cancer: Results of a Sub-Study of the UCBG- UNIRAD Trial

Downloads 134 (558,171)

Association between Daily Timing of Everolimus Combined with Adjuvant Endocrine Therapy with Survival Outcomes in Patients with High-Risk Hormone Positive and Her2 Negative Early Breast Cancer: Results of a Sub-Study of the UCBG- UNIRAD Trial

Number of pages: 39 Posted: 27 Mar 2025
Enora Laas, Anne-Sophie Hamy-Petit, Thomas Bachelot, Paul Gougis, Jérôme Lemonnier, Fabrice Andre, David Cameron, Judith M. Bliss, Sylvie Chabaud, Anne-Claire Hardy-Bessard, Magali Lacroix-Triki, Djelila Allouache, Marc Debled, Mario Campone, Laurence Venat, Paul Henri Cottu, Mathilde Martinez, Julien Grenier, Florence Dalenc, Elise Dumas, Fabien REYAL, Bernard Asselain, Frédérique Penault-Llorca, Francis Lévi and Sylvie Giacchetti
PSL Research University - Institut Curie, Institut Curie - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Medical Oncology Department, Sorbonne University - Hôpital Pitié-Salpêtrière, UNICANCER, Gustave Roussy - Breast Cancer Unit, University of Edinburgh - Edinburgh Cancer Centre, Institute of Cancer Research (ICR) - Clinical Trials and Statistics Unit (ICR-CTSU), University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, Armorican Center for Radiotherapy, Medical Imaging, and Oncology (CARIO), University of Paris-Saclay - Institut Gustave Roussy, Centre François Baclesse, University of Bordeaux - Institut Bergonié, Institut de Cancerologie de l’Ouest, Hôpital Universitaire Dupuytren, École Normale Supérieure - PSL Research University - Institut Curie, Clinique Pasteur, Sainte Catherine Institute, Institut Claudius Regaud - IUCT-Oncopole, CRCT, Inserm, Université Paris Cité, PSL Research University - Institut Curie, UNICANCER, Centre Jean Perrin, Université Paris Saclay and Hopital Saint-Louis
Downloads 102 (684,532)

Abstract:

Loading...

breast cancer, endocrine therapy, everolimus, circadian rhythm, intake timing

Association between Daily Timing of Everolimus Combined with Adjuvant Endocrine Therapy with Survival Outcomes in Patients with High-Risk Hormone Positive and Her2 Negative Early Breast Cancer: Results of a Sub-Study of the Ucbg- Unirad Trial

Number of pages: 39 Posted: 17 Apr 2025
Enora Laas, Anne-Sophie Hamy-Petit, Thomas Bachelot, Paul Gougis, Jérôme Lemonnier, Fabrice Andre, David Cameron, Judith M. Bliss, Sylvie Chabaud, Anne-Claire Hardy-Bessard, Magali Lacroix-Triki, Djelila Allouache, Marc Debled, Mario Campone, Laurence Venat, Paul Henri Cottu, Mathilde Martinez, Julien Grenier, Florence Dalenc, Elise Dumas, Fabien REYAL, Bernard Asselain, Frédérique Penault-Llorca, Francis Albert Lévi and Sylvie Giacchetti
PSL Research University - Institut Curie, Institut Curie - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Medical Oncology Department, Sorbonne University - Hôpital Pitié-Salpêtrière, UNICANCER, Gustave Roussy - Breast Cancer Unit, University of Edinburgh - Edinburgh Cancer Centre, Institute of Cancer Research (ICR) - Clinical Trials and Statistics Unit (ICR-CTSU), University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, Armorican Center for Radiotherapy, Medical Imaging, and Oncology (CARIO), University of Paris-Saclay - Institut Gustave Roussy, Centre François Baclesse, University of Bordeaux - Institut Bergonié, Institut de Cancerologie de l’Ouest, Hôpital Universitaire Dupuytren, École Normale Supérieure - PSL Research University - Institut Curie, Clinique Pasteur, Sainte Catherine Institute, Institut Claudius Regaud - IUCT-Oncopole, CRCT, Inserm, Université Paris Cité, PSL Research University - Institut Curie, UNICANCER, Centre Jean Perrin, University of Warwick - Cancer Chronotherapy Team and Hopital Saint-Louis
Downloads 32 (1,385,838)

Abstract:

Loading...

Breast cancer, endocrine therapy, everolimus, Circadian rhythm, intake timing

2.

Current and Evolutionary Analysis of Early Relapsed Metastatic Triple Negative Breast Cancer in the Nationwide ESME Cohort

Number of pages: 24 Posted: 12 Apr 2023
Thomas Grinda, Alison Antoine, William Jacot, Paul Henri Cottu, Thibault De La Motte Rouge, Jean Sebastien Frenel, Audrey mailliez, Florence Dalenc, Anthony Goncalves, Florian Clatot, Marie-Ange Mourer-Reynier, Christelle Levy, Jean-Marc FERRERO, Isabelle Desmoulins, Lionel Uwer, Thierry Petit, Christelle Jouannaud, Monica Arnedos, Michaël Chevrot, Coralie Courtinard, Olivier Tredan, Etienne Brain, David Pérol, Barbara Pistilli and Suzette Delaloge
Gustave Roussy, University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, University of Montpellier, École Normale Supérieure - PSL Research University - Institut Curie, Institut Curie - Department of Medical Oncology, Institut de Cancérologie de l’Ouest Pays de Loire, CHU Lille - Centre Oscar Lambret, Institut Claudius Regaud - IUCT-Oncopole, CRCT, Inserm, Aix-Marseille University, Centre Henri Becquerel, Centre Jean Perrin, Centre François Baclesse - Department of Medical Oncology, Centre François Baclesse, Institut de Cancérologie de Bourgogne, Institut de Cancérologie de Lorraine, Centre Paul Strauss, Institut Jean Godinot - Department of Medical Oncology, Bergonié Institute, R&D Unicancer, R&D Unicancer, University of Claude Bernard Lyon 1 - Medical Oncology Department, Institut Curie - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, Gustave Roussy - Breast Cancer Unit and Gustave Roussy Villejuif
Downloads 53 (1,031,043)

Abstract:

Loading...

Key words: breast cancer, triple-negative breast cancer, real-world data, ESME cohort, overall survival, ESME cohort

3.

Definition of Visceral Crisis in Hormone Receptor-Positive Her2-Negative Advanced Breast Cancer: Delphi Consensus Among Experts from the Unicancer French Breast Cancer Intergroup

Number of pages: 24 Posted: 06 Dec 2024
Rébecca NABETH, Mael Barthoulot, Audrey mailliez, Paul Henri Cottu, Jean-Yves Pierga, Sylvie Giacchetti, Julien Grenier, Véronique Dieras, Thibault De La Motte Rouge, Thomas Bachelot, Nicolas Penel, Manuel Rodrigues and Aurélie Moreira
affiliation not provided to SSRN, University of Lille II - Centre Oscar Lambret, CHU Lille - Centre Oscar Lambret, École Normale Supérieure - PSL Research University - Institut Curie, PSL Research University - Institut Curie, Hopital Saint-Louis, Sainte Catherine Institute, Centre Eugene Marquis, Institut Curie - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Lille II - Centre Oscar Lambret, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 39 (1,196,171)

Abstract:

Loading...

Key words: advanced breast cancer, visceral crisis, consensus, Delphi method